Athugið: Innihaldsefni skráð á lista yfir takmörkuð efni
EC/CAS
215-185-5/1310-73-2
Heiti efnisins
sodium hydroxide
Styrkur
0.5%<=C<2%
EC/CAS
231-791-2/7732-18-5
Heiti efnisins
Water, distilled, conductivity or of similar purity H2O
Styrkur
10%<=C<25%
Almennar upplýsingar
Version
5.01
Dagsetning endurskoðunar
2025-02-04
Vöruheiti
Methylprednisolone Acetate Injectable Suspension, Single-Dose Vial PZ01044
Vöruheiti
Methylprednisolone Acetate Injectable Suspension, Single-Dose Vial PZ01044
a. Viðskiptaheiti:
DEPO-MEDROL; DEPO-NISOLONE; DEPO-MEDRONE; DEPO-MODERIN; DEPO-MEDOL; DEPO-MEDRATE
1.3 Samheiti:
PNU-8210
1.2 Efnaheiti:
Glucocorticoid
Viðeigandi notkun
Hlutabréf afurðarnotkunar sem Anti-inflammatory
Neyðarnúmer
1-800-424-9300
Tákn í SDS
Fyrirtækjaupplýsingar
company
Pfizer Inc
tölvupóstur
pfizer-MSDS@pfizer.com
GHS upplýsingar
Merkisorð
Hætta
Hazard Codes
Hættuyfirlýsingar (CLP)
H360D, H373, H411
Hættuyfirlýsingar
Kóði
Yfirlýsingar
H360D
May damage the unborn child
H373
May cause damage to organs through prolonged or repeated exposure
H411
Toxic to aquatic life with long lasting effects